Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 13, Number 1—January 2007


Multidrug-resistant Acinetobacter Infection Mortality Rate and Length of Hospitalization

Rebecca H. Sunenshine*, Marc-Oliver Wright†, Lisa L. Maragakis‡, Anthony D. Harris†, Xiaoyan Song‡, Joan Hebden†, Sara E. Cosgrove‡, Ashley Anderson*, Jennifer Carnell*, Daniel B. Jernigan*, David G. Kleinbaum*, Trish M. Perl‡, Harold C. Standiford†, and Arjun Srinivasan*Comments to Author 
Author affiliations: *Centers for Disease Control and Prevention, Atlanta, Georgia, USA; †University of Maryland Medical School and Medical Center, Baltimore, Maryland, USA; ‡Johns Hopkins University, Baltimore, Maryland, USA;

Main Article

Table 1

Comparison of baseline characteristics of patients with multidrug-resistant (MDR) Acinetobacter infection with those with susceptible Acinetobacter infection and those without Acinetobacter infection, Baltimore hospitals, 2003– 2004*

CharacteristicMDR Acinetobacter, 
n = 96Susceptible Acinetobacter, 
n = 91p values for MDR Acinetobacter vs. susceptible, n = 187Uninfected, 
n = 89p values for MDR Acinetobacter vs. uninfected, n = 185
Median age, y54520.61520.97
Age range, y14–8312–8517–90
Sex, % male67570.78650.96
Mean modified APACHE III score (median)41 (42)36 (33)0.0232 (28)<0.001
Mean Charlson index (median)3.9 (3.0)2.8 (2.0)0.012.5 (2.0)<0.01

*APACHE III, Acute Physiology and Chronic Health Evaluation III.

Main Article

Top of Page The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO